Opportunistic infection drug research funds approved by NIAID.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D006801:Humans; D009316:National Institutes of Health (U.S.); D009894:Opportunistic Infections / Q000150:complications / Q000188:drug therapy*; D012109:Research Support as Topic; D014481:United States